NMRD (Nemaura Medical) Total Stockholders Equity: $-17.83 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nemaura Medical Total Stockholders Equity?

Nemaura Medical NMRD Total Stockholders Equity is $-17.83 Mil as of Dec. 2023.

Nemaura Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-17.83 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nemaura Medical's Book Value per Share for the quarter that ended in Dec. 2023 was $-0.62. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nemaura Medical's Debt-to-Equity for the quarter that ended in Dec. 2023 was -1.10.

Nemaura Medical  (OTCPK:NMRD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nemaura Medical's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-17.827-0)/28.899
=-0.62

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nemaura Medical's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(19.643 + 0) / -17.827
=-1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nemaura Medical Total Stockholders Equity Related Terms

Nemaura Medical Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Nemaura Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nemaura Medical Total Stockholders Equity Chart

Nemaura Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.23 -1.31 8.36 0.47 -11.81

Nemaura Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.86 -11.81 -14.38 -15.87 -17.83
What does a Total Stockholders Equity of $-17.83 Mil mean?
Nemaura Medical (NMRD) has a Total Stockholders Equity of $-17.83 Mil as of Dec. 2023. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Nemaura Medical and its competitors.
Is Nemaura Medical's Total Stockholders Equity too high?
Nemaura Medical's current Total Stockholders Equity is $-17.83 Mil.
How does Nemaura Medical's Total Stockholders Equity compare to THMO and MOTS?
Nemaura Medical's Total Stockholders Equity of $-17.83 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Nemaura Medical and its competitors. Nemaura Medical's current Total Stockholders Equity is $-17.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nemaura Medical stock overvalued right now?
Nemaura Medical (NMRD) has a current Total Stockholders Equity of $-17.83 Mil. The current Total Stockholders Equity is $-17.83 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Nemaura Medical (NMRD), the current Total Stockholders Equity is $-17.83 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nemaura Medical Business Description

Address 57 West 57th Street, New York, NY, USA, 10019
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.